英文名稱(chēng) | Alirocumab |
---|---|
中文名稱(chēng) | 阿利庫(kù)單抗;阿莫羅布單抗; 阿利西尤單抗 |
CAS號(hào) | 1245916-14-6 |
外觀 | A liquid |
儲(chǔ)存條件 | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專(zhuān)享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | 3-5days | ¥3000.00 | 登錄后可見(jiàn) | |
5 mg | 3-5days | ¥12500.00 | 登錄后可見(jiàn) | |
10 mg | 3-5days | ¥20000.00 | 登錄后可見(jiàn) | |
50 mg | 3-5days | ¥80000.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥125000.00 | 登錄后可見(jiàn) |
英文名稱(chēng) | Alirocumab |
---|---|
中文名稱(chēng) | 阿利庫(kù)單抗;阿莫羅布單抗; 阿利西尤單抗 |
CAS號(hào) | 1245916-14-6 |
外觀 | A liquid |
儲(chǔ)存條件 | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
Alirocumab (anti-PCSK9) works by inhibiting the PCSK9 protein, which binds to the low-density lipoprotein receptor (LDLR) and causes receptor degradation, removing less LDL cholesterol from the circulation.